# Chemotherapy in Treating Patients With Prostate Cancer

> **NCT00004045** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** exatecan mesylate

## Key facts

- **NCT ID:** NCT00004045
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2001-08
- **Final completion:** 2001-08
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004045, "Chemotherapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*